Pulsenmore Ltd.

Pulsenmore Ltd. has announced a strategic partnership with Ouma Health, a leading provider of virtual maternity care solutions in the United States. This collaboration will integrate Pulsenmore's FDA-authorized home ultrasound platform into Ouma Health's virtual maternity care model, enabling clinicians to extend prenatal ultrasound monitoring into patients' homes. The initiative aims to expand access to remote prenatal care, particularly in maternal care deserts and underserved communities, marking a significant expansion for Pulsenmore in the U.S. maternal health market.

Pulsenmore Ltd. has postponed its Annual General Meeting of Shareholders (AGM) from June 16, 2026, to July 9, 2026, at 10:00 a.m. (Israel time). The company stated the postponement is to allow shareholders additional time to consider the proposals and submit their proxies. The record date and the proposals to be voted on remain unchanged, and previously submitted proxies will remain valid.

Pulsenmore Ltd. announced it will hold its Annual General Meeting of Shareholders on June 16, 2026, in Ramat Gan, Israel. Key agenda items include the re-election and election of Class I directors, approval of the 2026 bonus plan for CEO Dr. Elazar Sonnenschein, and approval of 2025 discretionary cash bonuses for both the CEO and VP R&D Menashe Sonnenschein. Shareholders will also vote on the Amended and Restated Compensation Policy and the re-appointment of PwC as the independent auditor for fiscal year 2026.